首页 工具
登录
购物车
DORA-22

DORA-22

产品编号 T5500   CAS 1088991-95-0

DORA-22 是一种双食欲素受体拮抗剂,可改善轻度压力引起的失眠,对记忆的影响很小。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
DORA-22 Chemical Structure
DORA-22, CAS 1088991-95-0
规格 价格/CNY 货期 数量
1 mg ¥ 1,290 现货
2 mg ¥ 1,930 现货
5 mg ¥ 2,920 现货
10 mg ¥ 4,320 现货
25 mg ¥ 6,890 现货
50 mg ¥ 9,330 现货
100 mg ¥ 12,500 现货
1 mL * 10 mM (in DMSO) ¥ 3,220 现货
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
重组蛋白限时优惠
Doxorubicin hydrochloride限时半价
产品目录号及名称: DORA-22 (T5500)
点击图片重新获取验证码
选择批次  
纯度: 99.73%
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 DORA-22 is a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory
体内活性 DORA-22, a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory.DORA-22 treatment improved the insomnia-related sleep disruption-wake was attenuated and NREM sleep was normalized.?REM sleep amounts were enhanced compared with vehicle treatment for one dose (30 mg/kg).?In the first hour of insomnia model exposure, DORA-22 promoted the number and average duration of NREM sleep spindles, which have been previously proposed to play a role in memory consolidation (all doses).?Water maze measures revealed probe trial performance improvement for select doses of DORA-22, including increased time spent in the platform quadrant (10 and 30 mg/kg) and time spent in platform location and number of platform crossings (10 mg/kg only).?In conclusion, DORA-22 treatment improved insomnia-related sleep disruption and memory consolidation deficits[1].
动物实验 Animals were first trained to remember the location of a hidden platform (acquisition) in the Morris Water Maze and then administered DORA-22 (10, 30, or 100 mg/kg doses) or vehicle control.?Animals were then subjected to a rodent insomnia model involving two exposures to dirty cages over a 6-hr time period (at time points 0 and 3 hr), followed immediately by a probe trial in which memory of the water maze platform location was evaluated[1].
分子量 424.44
分子式 C23H22F2N4O2
CAS No. 1088991-95-0

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 10 mg/mL (23.56 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.356 mL 11.7802 mL 23.5605 mL 58.9011 mL
5 mM 0.4712 mL 2.356 mL 4.7121 mL 11.7802 mL
10 mM 0.2356 mL 1.178 mL 2.356 mL 5.8901 mL
20 mM 0.1178 mL 0.589 mL 1.178 mL 2.9451 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Gamble M C , Katsuki F , Mccoy J G , et al. The dual orexinergic receptor antagonist DORA-22 improves the sleep disruption and memory impairment produced by a rodent insomnia model[J]. Sleep, 2019. 2. Duncan M J , Farlow H , Tirumalaraju C , et al. Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice[J]. Alzhmer's & Dementia: Translational Research & Clinical Interventions, 2019, 5:70-80.
OXA (17-33) acetate Orexin 2 Receptor Agonist SB-408124 YNT-185 Daridorexant hydrochloride Almorexant hydrochloride TCS 1102 TCS-OX2-29

相关化合物库

该产品包含在如下化合物库中:
GPCR靶点分子库 抑制剂库 NO PAINS 化合物库 神经信号分子库 已知活性化合物库 经典已知活性库 表型筛选靶点鉴定库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

DORA-22 1088991-95-0 GPCR/G Protein Neuroscience OX Receptor DORA 22 DORA22 Inhibitor inhibitor inhibit

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼